BSG House
226-236 City Road
LONDON
EC1V 2TT
According to BCC Research ‘The worldwide value of bioinformatics is expected to grow to $3.0 billion in 2010, at an average annual growth rate of 15.8%.’
The bioinformatics market is driven by the need of pharmaceutical and biotechnology companies to increase the efficiency of their drug-discovery and development efforts. The focus is now on target validation for translating genomic information into knowledge for developing therapeutics, proteomics and the changing trends in the drug discovery procedures.
Visiongains’s bioinformatics conference will provide an ideal platform for the attendees to get an overview of the recent advances and challenges in this area and provide a novel outlook on emerging technologies and next generation business models.
For further information please see the event website: